Cell Therapeutics Signs Financing Agreement
by lokety on Jun.22, 2006, under Posts
Cell Therapeutics (CTIC) has entered a financing agreement with Societe Generale Group for the French bank to buy $55M new shares to trade on the Italian stock exchange.
Societe Generale Group will have the option to purchase an additional $17M over the next 24 months.
CTIC is a biotechnology company that develops drugs to combat cancer and related conditions. It’s flagship product, XYOTAX, is undergoing trails for approval and sale.
Source: The Associated Press
<URL:http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20060621&ID=5812747>
Technorati Tags: cell therapeutics, societe generale group, shares, biotechnology, xyotax, market, financing agreement
Related posts:
- Cell Therapeutics to Submit New XYOTAX Drug Trial to FDA
- Cell Therapeutics Signs Deal With Norvatis
- Cell Therapeutics To Suspend Enrollment for PIONEER Drug Trial
Buy Stock Images
iStockphoto.com - Newest Uploads
The world's fastest growing royalty-free stock photography collection
Tree bark and root details Monday, 4 January 2010, 11:20 am
Dry and worn details of a tree bark and rootSource:
iStockphoto.com - Newest Uploads | lokety
Big American Breakfast Monday, 4 January 2010, 1:25 am
A large serving of breakfast including steak, bacon, sausages, fries, eggs, tomatoes and toast.Source:
Loading ...
